{
    "id": 1172,
    "fullName": "NRAS G13X",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "NRAS G13X indicates any NRAS missense mutation that results in replacement of the glycine (G) at amino acid 13 by a different amino acid. NRAS codon 13 mutations are hotspot mutations that often result in decreased Nras GTPase activity and transformation of cultured cells (PMID: 17517660, PMID: 26985062).",
            "references": [
                {
                    "id": 12404,
                    "pubMedId": 26985062,
                    "title": "RAS isoforms and mutations in cancer at a glance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26985062"
                },
                {
                    "id": 2101,
                    "pubMedId": 17517660,
                    "title": "NRAS mutation causes a human autoimmune lymphoproliferative syndrome.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17517660"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 4893,
        "geneSymbol": "NRAS",
        "terms": [
            "NRAS",
            "ALPS4",
            "CMNS",
            "N-ras",
            "NCMS",
            "NRAS1",
            "NS6"
        ]
    },
    "variant": "G13X",
    "createDate": "07/27/2014",
    "updateDate": "11/12/2019",
    "referenceTranscriptCoordinates": {
        "id": 162446,
        "transcript": "NM_002524",
        "gDna": "chr1:g.114716122_114716124",
        "cDna": "c.37_39",
        "protein": "p.G13",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17105,
            "approvalStatus": "FDA contraindicated",
            "evidenceType": "Actionable",
            "efficacyEvidence": "Erbitux (cetuximab) treatment of colorectal cancer patients with NRAS exon 2, codon 13 mutations is contraindicated (FDA.gov).",
            "molecularProfile": {
                "id": 1197,
                "profileName": "NRAS G13X"
            },
            "therapy": {
                "id": 694,
                "therapyName": "Cetuximab",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 15479,
                    "pubMedId": null,
                    "title": "Erbitux (cetuximab) FDA Drug Label",
                    "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125084"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        },
        {
            "id": 17119,
            "approvalStatus": "FDA contraindicated",
            "evidenceType": "Actionable",
            "efficacyEvidence": "Vectibix (panitumumab) treatment of colorectal cancer patients with NRAS exon 2, codon 13 mutations is contraindicated (FDA.gov).",
            "molecularProfile": {
                "id": 1197,
                "profileName": "NRAS G13X"
            },
            "therapy": {
                "id": 845,
                "therapyName": "Panitumumab",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 15480,
                    "pubMedId": null,
                    "title": "Vectibix (panitumumab) FDA Drug Label",
                    "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125147"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        },
        {
            "id": 13669,
            "approvalStatus": "Guideline",
            "evidenceType": "Prognostic",
            "efficacyEvidence": "NRAS G13X is associated with a poor prognosis in patients with myelodysplastic syndrome (NCCN.org).",
            "molecularProfile": {
                "id": 1197,
                "profileName": "NRAS G13X"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 50908,
                "name": "myelodysplastic syndrome",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1197,
            "profileName": "NRAS G13X",
            "profileTreatmentApproaches": [
                {
                    "id": 16540,
                    "name": "RAS Inhibitor (Pan)",
                    "profileName": "NRAS G13X"
                },
                {
                    "id": 16535,
                    "name": "MEK inhibitor (Pan)",
                    "profileName": "NRAS G13X"
                },
                {
                    "id": 16538,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "NRAS G13X"
                },
                {
                    "id": 16536,
                    "name": "MEK1 Inhibitor",
                    "profileName": "NRAS G13X"
                },
                {
                    "id": 16539,
                    "name": "PIK3CA inhibitor",
                    "profileName": "NRAS G13X"
                },
                {
                    "id": 16537,
                    "name": "MEK2 Inhibitor",
                    "profileName": "NRAS G13X"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 162446,
            "transcript": "NM_002524",
            "gDna": "chr1:g.114716122_114716124",
            "cDna": "c.37_39",
            "protein": "p.G13",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}